Study Evaluating 111In-Panitumumab for Nodal Staging in Head and Neck Cancer

Summary

The primary purpose of the study is to assess the safety of 111In-panitumumab as a molecular imaging agent in patients with Head and Neck Squamous Cell Carcinoma. The secondary objective is to compare sensitivity and specificity of identifying sentinel lymph nodes by systemic injection of 111In-panitumumab prior to Day of Surgery versus conventional local injection with an optical dye at the time of surgery.

Timeline

Start

2021-03-30

Primary completion

2027-03

Completion

2027-03

Drugs

Indications